United States v. Dean Walker

858 F.3d 196, 2017 WL 2261537, 2017 U.S. App. LEXIS 9033
CourtCourt of Appeals for the Fourth Circuit
DecidedMay 24, 2017
Docket16-4367
StatusPublished
Cited by6 cases

This text of 858 F.3d 196 (United States v. Dean Walker) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Dean Walker, 858 F.3d 196, 2017 WL 2261537, 2017 U.S. App. LEXIS 9033 (4th Cir. 2017).

Opinion

TRAXLER, Circuit Judge:

Dean Washington Walker, a native of Jamaica, pleaded guilty to illegal re-entry after being convicted of an aggravated felony. See 8 U.S.C. § 1326(b)(2). At sentencing, the district court concluded that Walker’s prior drug conviction in Ohio qualified as a “drug trafficking offense,” and the district court therefore applied the 16-level enhancement called for by the then-current version of U.S.S.G. § 2L1.2(b)(l)(A)(i) (2015). With the 16-level enhancement, Walker’s offense level was 21, which, when combined with his category III criminal history, yielded an advisory sentencing range of 46-57 months. The district court varied downward and sentenced Walker to 30 months’ imprisonment.

Walker appeals, challenging only the application of the 16-level enhancement. Finding no error, we affirm.

I.

To determine whether a prior conviction qualifies as a predicate offense under § 2L1.2, we apply the categorical ap *198 proach, comparing the elements of the underlying offense to the federal definition. See, e.g., United States v. Alfaro, 835 F.3d 470, 472 (4th Cir. 2016). If the elements of the underlying offense “correspond! ] in substance” to the federal definition, Taylor v. United States, 495 U.S. 575, 599, 110 S.Ct. 2143, 109 L.Ed.2d 607 (1990), the underlying offense categorically qualifies for the enhancement.

In 2004, Walker pleaded guilty to a charge of drug trafficking under Ohio law. The statute under which he was convicted states:

No person shall knowingly ... [p]repare for shipment, ship, transport, deliver, prepare for distribution, or distribute a controlled substance or a controlled substance analog, when the offender knows or has reasonable cause to believe that the controlled substance or a controlled substance analog is intended for sale or resale by the offender or another person.

Ohio Rev. Code Ann. § 2925.03(A)(2).

At the time of Walker’s sentencing, U.S.S.G. § 2L1.2 provided for a 16-level enhancement in illegal entry cases where the defendant was deported after “a conviction for a felony that is ... a drug trafficking offense for which the sentence imposed exceeded 13 months.” U.S.S.G. § 2L1.2(b)(l)(A)(i) (2015). 1 The Commentary to § 2L1.2 defined “drug trafficking offense” as

an offense under federal, state, or local law that prohibits the manufacture, import, export, distribution, or dispensing of, or offer to sell a controlled substance (or a counterfeit substance) or the possession of a controlled substance (or a counterfeit substance) with intent to manufacture, import, export, distribute, or dispense.

U.S.S.G. § 2L1.2, cmt. n.1(B)(iv) (2015) (emphasis added).

A.

Focusing on the “with intent to manufacture ...” language of the Guidelines, Walker argues that his Ohio conviction does not qualify as a drug trafficking offense because the statute requires only that the defendant act knowingly rather than with specific intent, as he contends is required by the Guidelines. According to Walker, his prior conviction qualifies only as a “felony,” which warrants a 4-level enhancement under § 2L1.2(b)(1)(D). We disagree.

Walker’s argument is based on a misreading of the Guidelines’ definition of a “drug trafficking offense.” As Walker reads the definition, the “with intent ...” language applies to every one of the listed prohibited acts, not just to the act of possession. Walker thus effectively rewrites the definition of “drug trafficking offense” to read:

an offense under federal, state, or local law that prohibits the manufacture, import, export, distribution, possession or dispensing of, or offer to sell a controlled substance (or a counterfeit substance) or the possession of a controlled substance (or a counterfeit substance) with intent to manufacture, import, export, distribute, or dispense.

Of course, we must apply the definition as written, not as Walker wishes it were written. Given the Guidelines’ repetition of the object of the prohibited acts—“controlled substance (or a counterfeit substance),” it *199 is clear that “drug trafficking offense” encompasses two kinds of offenses: (1) offenses involving the manufacturing, importation, or distribution of controlled (or counterfeit) substances, and (2) offenses involving possession of controlled (or counterfeit) substances where that possession is for the specific purpose of engaging in distribution-related activities. See United States v. Ponce-Rodriguez, 863 F.Supp.2d 536, 539 (E.D. Va. 2012) (“An offense of conviction constitutes a ‘drug trafficking offense’ under § 2L1.2 if, and only if, the offense actually required proof of either (i) ‘the manufacture, import, export, distribution, or dispensing of, or offer to sell a controlled substance (or a counterfeit substance)’ or (ii) ‘the possession of a controlled substance (or a counterfeit substance) with intent to manufacture, import, export, distribute, or dispense.’ ” (quoting U.S.S.G. § 2L1.2, cmt. n.1(B)(iv))). This reading of the Guidelines’ definition makes sense, as courts have long distinguished between mere possession of drugs and trafficking in drugs. See, e.g., Lopez v. Gonzales, 549 U.S. 47, 53-54, 127 S.Ct. 625, 166 L.Ed.2d 462 (2006) (noting that “ordinarily ‘trafficking’ means some sort of commercial dealing,” and rejecting argument that “would often turn simple possession into trafficking, just what the English language tells us not to expect”); United States v. Renteria-Martinez, 847 F.3d 297, 300 (5th Cir. 2017) (per curiam) (“Possession alone does not equate to drug trafficking.”).

We therefore conclude that, under the previous version of § 2L1.2, the specific “intent to manufacture, import, export, distribute, or dispense” is an element that must be established only for drug possession offenses. 2 The absence of a specific-intent requirement in the Ohio statute thus does not prevent Walker’s conviction from qualifying as a drug trafficking offense under U.S.S.G. § 2L1.2(b)(l)(A)(i) (2015).

B.

Because the absence of a specific-intent element in the Ohio statute does not preclude application of the 16-level sentence enhancement, the dispositive question is whether Ohio Rev. Code Ann. § 2925.03(A)(2) categorically qualifies as a statute prohibiting “the manufacture, import, export, distribution, or dispensing of, or offer to sell a controlled substance (or a counterfeit substance).” U.S.S.G. § 2L1.2, cmt. n.l(B)(iv) (2015).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Dennis Smith
960 F.3d 883 (Sixth Circuit, 2020)
United States v. Fernando Godinez
955 F.3d 651 (Seventh Circuit, 2020)
United States v. Thomas
939 F.3d 1121 (Tenth Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
858 F.3d 196, 2017 WL 2261537, 2017 U.S. App. LEXIS 9033, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-dean-walker-ca4-2017.